Correlation of Ki-67 expression in cutaneous primary melanoma with prognosis in a prospective study: Different correlation according to thickness

Journal of the American Academy of Dermatology

Volumn 44, Issue 2, 2001, Pages 188-192

  Moretti, Silvia ^a,b,c   Spallanzani, Adelina ^a,b,c   Chiarugi, Alessandra ^a,b,c   Fabiani, Massimo ^a,b,c   Pinzi, Cinzia ^a,b,c  

^a SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; KI 67 ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MELANOMA; MELANOMA CELL; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; THICKNESS;

EID: 0035116726     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2001.110067     Document Type: Article

References (17)

1. A computerized mathematical model and scoring system for predicting outcome in melanoma patients
2. Model predicting survival in stage I melanoma based on tumor progression
3. Prognostic index in malignant melanoma
4. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67
5. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluation in human malignancies
6. Cell proliferation kinetics in human solid tumors: Relation to probability of metastatic dissemination and long-term survival
7. Ki-67 immunostaining in melanocytic skin tumors: Correlation with histologic parameters
8. Prognostic significance of proliferation and motility in primary malignant melanoma of the skin
9. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections
10. MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas
11. MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma
12. Malignant melanoma of the skin (excluding eyelid)
13. Ki-67 expression correlates with tumor progression and HLA-DR antigen expression in melanocytic lesions
14. In situ expression of transforming growth factor beta is associated with melanoma progression and correlates with Ki-67, HLA-DR and beta3 integrin expression
15. Tumor cell growth fractions in human malignant melanomas and the correlation to histopathologic tumor grading
16. Prognostic significance of MIB-1 proliferative activity in thin melanomas and immunohistochemical analysis of MIB-1 proliferative activity in melanocytic tumors
17. Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions